M&T Bank
SRNE

M&T Bank’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

M&T Bank’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-14,570
Closed -$12.9K – 1768
2022
Q4 		$12.9K Hold
14,570
– – ﹤0.01% 1590
2022
Q3 		$23K Hold
14,570
– – ﹤0.01% 1555
2022
Q2 		$7K Buy
+14,570
New +$25.2K ﹤0.01% 1567
2016
Q2 		– Sell
-18,000
Closed -$97K – 1789
2016
Q1 		$97K Hold
18,000
– – ﹤0.01% 1563
2015
Q4 		$157K Buy
+18,000
New +$152K ﹤0.01% 1542
2015
Q3 		– Sell
-11,000
Closed -$194K – 2061
2015
Q2 		$194K Buy
+11,000
New +$141K ﹤0.01% 1789

Other funds holding SRNE

PP
Paloma Partners Greenwich, Connecticut $177M AUM 286.05% 1-Year Est. Return
OCM
Oaktree Capital Management Los Angeles, California $5.91B AUM 42.97% 1-Year Est. Return
OFA
Oaktree Fund Advisors Los Angles, California $56.9M AUM 80.32% 1-Year Est. Return
CGA
Crescent Grove Advisors Lake Forest, Illinois $1.01B AUM 17.78% 1-Year Est. Return
LCM
Lattice Capital Management Kirkland, Washington $56.9M AUM 49.15% 1-Year Est. Return
STB
S&T Bank Indiana, Pennsylvania $268M AUM 39.92% 1-Year Est. Return
GA
GoalVest Advisory New York $539M AUM 27.49% 1-Year Est. Return
HFRG
Houlihan Financial Resource Group Ashburn, Virginia $257M AUM 14.19% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
GBWM
Granite Bay Wealth Management Portsmouth, New Hampshire $470M AUM 15.4% 1-Year Est. Return